The ethics of withdrawal: The case of follow-up from first-in-human clinical trials

Research output: Contribution to journalReview articlepeer-review

3 Citations (SciVal)

Abstract

This paper aims to analyze whether patients should be allowed to veto research-related use of medical data collected during routine follow-ups after their withdrawal from first-in-human clinical trials. Forms of withdrawal are identified and it is argued that the right to withdraw might be limited to some of these. The paper concludes that if veto right is denied, then: the research participant should be informed about the potential use of his/her follow-up data in case of his/her withdrawal and consent to it; follow-up should not be initiated for research purposes; compulsory use of follow-up data should imply the use of data anyway collected, requiring no additional effort from the patient; and before deciding about the veto right, investigation of concerned patients’ value preferences is needed.
Original languageEnglish
Pages (from-to)25-36
JournalRegenerative Medicine
Volume12
Issue number1
DOIs
Publication statusPublished - 2017

Subject classification (UKÄ)

  • Medical Ethics

Keywords

  • ethics of withdrawal

Fingerprint

Dive into the research topics of 'The ethics of withdrawal: The case of follow-up from first-in-human clinical trials'. Together they form a unique fingerprint.

Cite this